Aortic Valve Market Research Report - Global Forecast till 2027

Global Aortic Valve Market: Information by Valve Type (Mechanical and Biological), Suture Type (Suture and Sutureless), Surgery Type (Minimally Invasive Surgery (Transfemoral, Transaortic Implantation, Transapical, and Trans-subclavian) and Open surgery), End-User (Hospitals, Ambulatory Surgery Centers) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2027

ID: MRFR/HC/7160-HCR | 90 Pages | Published By Kinjoll Dey on March 2023         

Aortic Valve Market Speak to Analyst Request a Free Sample

Aortic Valve Market

Aortic Valve Market held a value of USD 6,454.91 Million at a CAGR of 11.1% during the assessment period.

By Valve Type Mechanical Biological
By Suture Type Suture Sutureless
By Surgery Type Minimally Invasive Surgery Open surgery
By End-User Hospitals Ambulatory Surgery Centers
Key Players
Companies Profiled   Boston Scientific Corporation   Medtronic   Abbott Laboratories   LivaNova PLC   Edwards Lifesciences Corporation   CryoLife   Biotronik   Colibri Heart Valve   JenaValve   TTK HealthCare
Market Driving Forces   Increasing geriatric population   Growing prevalence of cardiovascular disorders
Request a Free Sample

Market Forecast

Aortic Valve Market held a value of USD 6,454.91 Million in 2018, at a CAGR of 11.1% during the assessment period of 2019 to 2025.

Market Synopsis

There has been significant growth in the adoption of minimally invasive surgeries in the past few years, which is why demand for aortic valves is also increasing. The key players involved in this market are actively focusing upon building partnerships, collaborations, and joint ventures with hospitals and ambulatory centers in different countries to strengthen their position in the market. Moreover, there is an increasing growth in cardiovascular diseases, which pushes the need for efficient aortic valves in the developing as well as underdeveloped regions.

Market Influencer

Several government authorities and associations from developed and developing regions have focused on increasing awareness about valve replacement procedures is contributing to the growth of the market. For instance, the European Society of Cardiology organizes ESC Congress where heart experts from more than 150 countries come together to attend scientific sessions.

Market Drivers

  • The increasing geriatric population is directly attributing to rising cardiac complications. According to the United Nations, in 2017, more than 960 people were aged 60 or above across the globe

  • The growing prevalence of cardiovascular disorders is providing favorable conditions for rising cardiac surgeries and eventually it is responsible for increasing demand for the aortic valve. For instance, Moreover, according to the European Cardiovascular Disease Statistics 2017, each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU)

  • Innovative and easy to use product launches in recent years

  • High investment in research and development for the development of efficient solutions

  • Increasing healthcare expenditure in developing countries is likely to provide favorable conditions for the growth of the market

  • Rising support from regulatory authorities to control cardiovascular diseases

Market Restraints

  • Product recalls due to the safety concerns are likely to hamper the market growth

  • Stringent regulatory landscape for approval of aortic valves


By Valve Type

  • Mechanical: Mechanical valve is the most common type used in the aortic valve replacement procedures. It is made up of plastic or metal and has a longer life than tissue valves. On-X Prosthetic Heart Valves, Medtronic open pivot, Abbott Regent are some well-known brands of mechanical valves. This segment is likely to hold the largest market share owing to the increasing number of transcatheter aortic valve in replacement procedures

  • Biological: The biological valves segment is expected to be the fastest-growing segment due to the rising adoption of biological valves and increasing prevalence of aortic stenosis in Western countries. According to the MRFR analysis, the prevalence of aortic stenosis in European countries is 0.2% in adults aged 50 to 59, 1.3% in adults aged 60 to 69, and up to 9.8% in patients 80 to 89.

By Surgery Type

  • Minimally invasive surgeries: This segment is estimated to hold maximum market share during the forecast period. The growth of this segment is attributed to the growing popularity of transcatheter aortic valve replacement due to the shorter hospital stays, less pain, and faster recovery as compared to other procedures. For instance, according to the Society of Thoracic Surgeons/ACC Transcatheter Valve Therapy (TVT), in the US, the number of TAVR procedures performed increased from 5,000 in 2007 to 50,000 in 2017.

  • Open surgery: Open surgeries are the most common procedures in aortic valve replacement. This segment holds significant market share during the forecast period due to the cost-effectiveness of open surgeries.

By End-User

  • Hospitals: The majority of the aortic valve replacement is surgically performed in hospitals. Thus, hospitals are major consumers of aortic valve replacement products. The market growth of the segment is majorly attributed to the increasing number of patients getting monitored with cardiovascular diseases, growing installation of cardiac valves, and the rising rate of cardiovascular procedures.

  • Ambulatory Surgery Centers: Ambulatory centers provide medical care on an outpatient basis, including diagnosis, observation, consultation, treatment, intervention, and rehabilitation services. Sometimes these centers can include advanced medical technology and procedures even when provided outside hospitals.

  • Others: It includes specialty centers, surgical centers

By Region

  • Americas: Americas is estimated to be the largest regional market owing to the presence of prominent players in the major countries in America. Major market players such as Boston Scientific Corporation, Medtronic, Abbott laboratories, and Edwards Lifesciences Corporation have a significant presence in the Americas. The region is anticipated to dominate the global aortic valve market owing to the rising prevalence of cardiovascular diseases in the region. According to the American College of Cardiology Foundation, in 2017 approximately 356,461 Americans had an out-of-hospital cardiac arrest.

  • Europe: The European region holds the second largest share as there is increasing support from regulatory authorities to control cardiovascular diseases. Moreover, the growing prevalence of heart diseases in the region has led to an increase in adoption of aortic valves.

  • Asia-Pacific: The Asia-Pacific region is anticipated to be the fastest-growing region in the global aortic valve market. This region is witnessing a surge due to the increasing geriatric population and changing lifestyle in developing countries such as India. According to the World Bank Group, Japan has the largest number of geriatric populations accounting for around 27.8% of the total population. Additionally, the increasing healthcare expenditure in this region is anticipated to drive growth in the market.

  • Middle East & Africa: The smallest market due to limited healthcare infrastructure and limited exposure to innovative solutions.

Key Players

  • Boston Scientific Corporation

  • Medtronic

  • Abbott Laboratories

  • LivaNova PLC

  • Edwards Lifesciences Corporation

  • CryoLife

  • Biotronik

  • Colibri Heart Valve

  • JenaValve

  • TTK HealthCare

  • Others

Report Scope:

Report Attribute/Metric Details
  Market Size   USD 6,454.91 Million
  CAGR   11.1%
  Base Year   2019
  Forecast Period   2025
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors and Trends
  Segments Covered   Valve Type, Surgery Type, End-User And Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Boston Scientific Corporation, Medtronic, Abbott Laboratories, LivaNova PLC, Edwards Lifesciences Corporation, CryoLife, Biotronik, Colibri Heart Valve, JenaValve, TTK HealthCare
  Key Market Opportunities   Adoption of minimally invasive surgeries
  Key Market Drivers

  • Innovative and easy to use product launches
  • High investment in research and development of efficient solutions
  • Increasing healthcare expenditure

  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Aortic Valve Market is projected to grow at approximately 11.1% CAGR during the assessment period (2019-2025).

    Aortic Valve Market had valued at around USD 6,454.91 MN in 2018.

    Surging prevalence of cardiac disorders and introduction of innovative products, are major tailwinds pushing the growth of the Global Aortic Valve Market.

    North America holds the largest share in the Global Aortic Valve Market, followed by Europe and the Asia Pacific, respectively.

    Medtronic(US), TTK HealthCare (India), Boston Scientific Corporation (US), JenaValve (US), Abbott Laboratories (US), Biotronik (Germany), Edwards Lifesciences Corporation (2025US), Colibri Heart Valve (US), LivaNova PLC (UK), and CryoLife (US), are some of the top players operating in the Global Aortic Valve Market.